Drug comparisons
Acetohexamide vs Alogliptin
Acetohexamide vs Alogliptin for T2DM: Compare sulfonylurea vs DPP-4 inhibitor on efficacy, side effects, warnings, and why one is outdated.
No comparison dimensions are available for this page.
Clinical context
This comparison is relevant for patients or clinicians reviewing outdated first-generation sulfonylureas against contemporary DPP-4 inhibitors for type 2 diabetes therapy.
Bottom line
While Alogliptin offers a more modern and generally safer profile than the rarely used Acetohexamide, treatment choice must be individualized.
All medication comparisons